Svenningsson, Anna Linnéa
Stomrud, Erik
Palmqvist, Sebastian
Hansson, Oskar
Ossenkoppele, Rik
Funding for this research was provided by:
Lund University
Article History
Received: 4 January 2022
Accepted: 11 September 2022
First Online: 4 October 2022
Declarations
:
: The study was approved by the ethics committee at Lund University and the participants gave their written informed consent.
: Not applicable.
: OH has acquired research support (for the institution) from ADx, AVID Radiopharmaceuticals, Biogen, Eli Lilly, Eisai, Fujirebio, GE Healthcare, Pfizer, and Roche. In the past 2 years, he has received consultancy/speaker fees from Amylyx, Alzpath, Biogen, Cerveau, Fujirebio, Genentech, Novartis, Roche, and Siemens. All other authors declare no competing interests.